FDA Inspection 1314968 - Kenneth S. Sharlin, MD - May 01, 2026

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Kenneth S. Sharlin, MD, with an inspection on May 1, 2026, issued by the Kansas City District Office, covering human drugs.

Company: Kenneth S. Sharlin, MD
Inspection Date: May 1, 2026
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · 21e6d47d-07ba-4327-89b6-db2f318cff7d

Violation Codes2

21 CFR 312.6021 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.